This compound is a selective β?-adrenergic receptor agonist with potent bronchodilator effects. It is widely used as a first-line anti-asthma drug for relieving bronchospasm in patients with bronchial asthma, chronic obstructive pulmonary disease (COPD), and emphysema. Its rapid onset and long duration of action make it suitable for both acute symptom relief and preventive treatment. In pharmaceutical synthesis, it serves as an active pharmaceutical ingredient (API) and a key intermediate for manufacturing other β?-agonists. It is also used in veterinary medicine for treating respiratory disorders in livestock. High purity and good water solubility ensure its efficacy in various dosage forms, including tablets, injections, and aerosols, playing a critical role in respiratory therapy.

This substance is classified as a GHS warning substance (H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation). Inhalation may cause cough, shortness of breath, or allergic reactions. Skin contact can lead to redness, itching, or dermatitis. Eye contact may result in severe irritation, tearing, or corneal damage. Ingestion may cause nausea, vomiting, tremors, or tachycardia. Operations should be performed in a well-ventilated area with dust masks, chemical-resistant gloves, and safety goggles. Avoid contact with strong oxidants and alkalis. Store separately from food and feed. In case of leakage, collect solids to prevent dust dispersion. Rinse skin with plenty of soapy water for 15 minutes. Flush eyes with clean water for at least 15 minutes and seek medical attention if irritation persists. If swallowed, drink plenty of water and do not induce vomiting; seek medical help promptly. Dispose of waste in accordance with local hazardous waste regulations.